Clinical Trial Update: Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease [Phase 1, Phase 2]

View source ↗

Summary

This is a clinical trial update on Trospium Chloride Inhalation Powder (TrIP) for chronic obstructive pulmonary disease, covering Phase 1 and Phase 2 studies th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trospium Chloride Inhalation Powder (TrIP) (trospium chloride inhalation powder)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: COMPLETED